Home

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) red flags

CIK 0000315545 路 Knoxville, TN 路 SIC 2834 路 All EDGAR filings

7 verified red-flag event(s) since 2024-10-16.

3PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Going-concern doubt (10-Q)nano2026-08-13
quarterly (unaudited) disclosure 路 company history
3PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Going-concern doubt (10-Q)nano2026-05-14
quarterly (unaudited) disclosure 路 company history
4PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Going-concern doubtnano2026-03-26
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. 路 company history
3PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Going-concern doubt (10-Q)nano2025-11-13
quarterly (unaudited) disclosure 路 company history
3PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Going-concern doubt (10-Q)nano2025-08-14
quarterly (unaudited) disclosure 路 company history
4PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Going-concern doubt (10-Q)nano2025-05-14
quarterly (unaudited) disclosure; also within 90 days: Auditor change 路 company history
2PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Auditor changenano2025-04-16
routine: audit firm merged/was acquired; also within 90 days: Going-concern doubt 路 company history

What happened next

FlagDateCap at flag30d90d180d
Going-concern doubt2026-08-13$23.5M-3.3%pendingpending
Going-concern doubt2026-05-14$29.4M-9.8%-16.4%pending
Going-concern doubt2026-03-26$20.0M-3.6%+28.0%-3.0%
Going-concern doubt2025-11-13$27.1M-5.5%-32.3%+10.0%
Going-concern doubt2025-08-14$36.7M-15.3%-27.0%-48.6%
Going-concern doubt2025-05-14$35.1M-12.4%+3.4%-30.6%
Auditor change2025-04-16$41.0M-15.7%-26.0%-20.7%

Stock return after each flag; pending = window not yet elapsed; n/a = no price data.

Get the weekly "Red Flags" newsletter

The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.

Newsletter delivered by beehiiv. See our privacy policy.